Rauschenfels, S., Krassmann, M., Al-Masri, A. N., Verhagen, W., Leonhardt, J.,
Kuebler, J. F. & Petersen, C. Incidence of hepatotropic viruses in biliary atresia. Eur.
J. Pediatr. 168, 469-476 (2009).
Lorent, K., Gong, W., Koo, K. A., Waisbourd-Zinman, O., Karjoo, S., Zhao, X., Sealy,
I., Kettleborough, R. N., Stemple, D. L., Windsor, P. A., Whittaker, S. J., Porter, J. R.,
Wells, R. G. & Pack, M. Identification of a plant isoflavonoid that causes biliary
atresia. Sci. Transl. Med. 7, 286ra267 (2015).
Tan, C. E. & Moscoso, G. J. The developing human biliary system at the porta hepatis
level between 11 and 25 weeks of gestation: a way to understanding biliary atresia.
Part 2. Pathol. Int. 44, 600-610 (1994).
Tsai, E. A., Grochowski, C. M., Loomes, K. M., Bessho, K., Hakonarson, H., Bezerra,
J. A., Russo, P. A., Haber, B. A., Spinner, N. B. & Devoto, M. Replication of a GWAS
signal in a Caucasian population implicates ADD3 in susceptibility to biliary atresia.
Hum. Genet. 133, 235-243 (2014).
Harada, K., Sato, Y., Itatsu, K., Isse, K., Ikeda, H., Yasoshima, M., Zen, Y., Matsui, A.
& Nakanuma, Y. Innate immune response to double-stranded RNA in biliary
epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology 46,
87
1146-1154 (2007).
Bezerra, J. A., Wells, R. G., Mack, C. L., Karpen, S. J., Hoofnagle, J. H., Doo, E. &
Sokol, R. J. BILIARY ATRESIA: Clinical and Research Challenges for the 21(st)
Century. Hepatology (2018).
Hartley, J. L., Davenport, M. & Kelly, D. A. Biliary atresia. Lancet 374, 1704-1713
(2009).
Zahm, A. M., Hand, N. J., Boateng, L. A. & Friedman, J. R. Circulating microRNA is
a biomarker of biliary atresia. J. Pediatr. Gastroenterol. Nutr. 55, 366-369 (2012).
Song, Z., Dong, R., Fan, Y. & Zheng, S. Identification of serum protein biomarkers in
biliary atresia by mass spectrometry and enzyme-linked immunosorbent assay. J.
Pediatr. Gastroenterol. Nutr. 55, 370-375 (2012).
10
Zhao, D., Han, L., He, Z., Zhang, J. & Zhang, Y. Identification of the plasma
metabolomics as early diagnostic markers between biliary atresia and neonatal
hepatitis syndrome. PLoS One 9, e85694 (2014).
11
Golden, J., Zagory, J. A., Fenlon, M., Goodhue, C. J., Xiao, Y., Fu, X., Wang, K. S. &
Gayer, C. P. Liquid chromatography-mass spectroscopy in the diagnosis of biliary
atresia in children with hyperbilirubinemia. J. Surg. Res. 228, 228-237 (2018).
12
Cabrera-Abreu, J. C. & Green, A. Gamma-glutamyltransferase: value of its
88
measurement in paediatrics. Ann. Clin. Biochem. 39, 22-25 (2002).
13
Rendón-Macías, M. E., Villasís-Keever, M. A., Castañeda-Muciño, G. & SandovalMex, A. M. Improvement in accuracy of gamma-glutamyl transferase for differential
diagnosis of biliary atresia by correlation with age. Turk. J. Pediatr. 50, 253-259
(2008).
14
Chen, X., Dong, R., Shen, Z., Yan, W. & Zheng, S. Value of Gamma-Glutamyl
Transpeptidase for Diagnosis of Biliary Atresia by Correlation With Age. J. Pediatr.
Gastroenterol. Nutr. 63, 370-373 (2016).
15
Dillman, J. R., DiPaola, F. W., Smith, S. J., Barth, R. A., Asai, A., Lam, S., Campbell,
K. M., Bezerra, J. A., Tiao, G. M. & Trout, A. T. Prospective Assessment of Ultrasound
Shear Wave Elastography for Discriminating Biliary Atresia from other Causes of
Neonatal Cholestasis. J. Pediatr. 212, 60-65.e63 (2019).
16
Nguyen, M., Dossa, A., Zagory, J., Golden, J., Roberts, A., Fu, X., Wang, K. & Gayer,
C. P. Liquid chromatography-mass spectroscopy as a tool in the rapid diagnosis of
biliary atresia: a pilot study. J. Pediatr. Surg. 51, 923-926 (2016).
17
Peng, X., Yang, L., Liu, H., Pang, S., Chen, Y., Fu, J., Chen, Y., Wen, Z., Zhang, R.,
Zhu, B., Yu, J. & Invernizzi, P. Identification of Circulating MicroRNAs in Biliary
Atresia by Next-Generation Sequencing. J. Pediatr. Gastroenterol. Nutr. 63, 518-523
89
(2016).
18
Dong, R., Shen, Z., Zheng, C., Chen, G. & Zheng, S. Serum microRNA microarray
analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for
biliary atresia. Sci. Rep. 6, 21084 (2016).
19
Chen, P., Zhong, Z., Jiang, H., Chen, H., Lyu, J. & Zhou, L. Th17-associated cytokines
multiplex testing indicates the potential of macrophage inflammatory protein-3
alpha in the diagnosis of biliary atresia. Cytokine 116, 21-26 (2019).
20
Behairy, O. G., Elsadek, A. E., Behiry, E. G., Elhenawy, I. A., Shalan, N. H. & Sayied,
K. R. Clinical Value of Serum Interleukin-33 Biomarker in Infants With Neonatal
Cholestasis. J. Pediatr. Gastroenterol. Nutr. 70, 344-349 (2020).
21
Ukarapol, N., Wongsawasdi, L., Ong-Chai, S., Riddhiputra, P. & Kongtawelert, P.
Hyaluronic acid: additional biochemical marker in the diagnosis of biliary atresia.
Pediatr. Int. 49, 608-611 (2007).
22
Muraji, T., Harada, T., Miki, K., Moriuchi, T., Obatake, M. & Tsugawa, C. Urinary
sulfated bile acid concentrations in infants with biliary atresia and breast-feeding
jaundice. Pediatr. Int. 45, 281-283 (2003).
23
Li, W. W., Yang, Y., Dai, Q. G., Lin, L. L., Xie, T., He, L. L., Tao, J. L., Shan, J. J. &
Wang, S. C. Non-invasive urinary metabolomic profiles discriminate biliary atresia
90
from infantile hepatitis syndrome. Metabolomics 14, 90 (2018).
24
Fukuoka, T., Bessho, K., Tachibana, M., Satomura, Y., Konishi, A., Yasuda, K.,
Kimura, T., Hasegawa, Y., Ueno, T., Miyoshi, Y. & Ozono, K. Total Bile Acid
Concentration in Duodenal Fluid Is a Useful Preoperative Screening Marker to Rule
Out Biliary Atresia. J. Pediatr. Gastroenterol. Nutr. 67, 383-387 (2018).
25
Lertudomphonwanit, C., Mourya, R., Fei, L., Zhang, Y., Gutta, S., Yang, L., Bove, K.
E., Shivakumar, P. & Bezerra, J. A. Large-scale proteomics identifies MMP-7 as a
sentinel of epithelial injury and of biliary atresia. Sci. Transl. Med. 9 (2017).
26
Yang, L., Zhou, Y., Xu, P. P., Mourya, R., Lei, H. Y., Cao, G. Q., Xiong, X. L., Xu, H.,
Duan, X. F., Wang, N., Fei, L., Chang, X. P., Zhang, X., Jiang, M., Bezerra, J. A. &
Tang, S. T. Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary
Atresia. Hepatology 68, 2069-2077 (2018).
27
Jiang, J., Wang, J., Shen, Z., Lu, X., Chen, G., Huang, Y., Dong, R. & Zheng, S. Serum
MMP-7 in the Diagnosis of Biliary Atresia. Pediatrics 144 (2019).
28
Wu, J. F., Jeng, Y. M., Chen, H. L., Ni, Y. H., Hsu, H. Y. & Chang, M. H. Quantification
of Serum Matrix Metallopeptide 7 Levels May Assist in the Diagnosis and Predict
the Outcome for Patients with Biliary Atresia. J. Pediatr. 208, 30-37.e31 (2019).
29
Davenport, M. Biliary atresia. Semin. Pediatr. Surg. 14, 42-48 (2005).
91
30
Davenport, M. Biliary atresia: clinical aspects. Semin. Pediatr. Surg. 21, 175-184
(2012).
31
Sundaram, S. S., Mack, C. L., Feldman, A. G. & Sokol, R. J. Biliary atresia:
Indications and timing of liver transplantation and optimization of pretransplant
care. Liver Transpl. 23, 96-109 (2017).
32
Vanier, M. T., Gissen, P., Bauer, P., Coll, M. J., Burlina, A., Hendriksz, C. J., Latour,
P., Goizet, C., Welford, R. W., Marquardt, T. & Kolb, S. A. Diagnostic tests for
Niemann-Pick disease type C (NP-C): A critical review. Mol. Genet. Metab. 118, 244254 (2016).
33
Raselli, T., Hearn, T., Wyss, A., Atrott, K., Peter, A., Frey-Wagner, I., Spalinger, M. R.,
Maggio, E. M., Sailer, A. W., Schmitt, J., Schreiner, P., Moncsek, A., Mertens, J.,
Scharl, M., Griffiths, W. J., Bueter, M., Geier, A., Rogler, G., Wang, Y. & Misselwitz,
B. Elevated oxysterol levels in human and mouse livers reflect nonalcoholic
steatohepatitis. J. Lipid Res. 60, 1270-1283 (2019).
34
Leoni, V. & Caccia, C. Potential diagnostic applications of side chain oxysterols
analysis in plasma and cerebrospinal fluid. Biochem. Pharmacol. 86, 26-36 (2013).
35
Alkazemi, D., Egeland, G., Vaya, J., Meltzer, S. & Kubow, S. Oxysterol as a marker
of atherogenic dyslipidemia in adolescence. J. Clin. Endocrinol. Metab. 93, 4282-4289
92
(2008).
36
Meng, L. J., Griffiths, W. J., Nazer, H., Yang, Y. & Sjovall, J. High levels of (24S)-24hydroxycholesterol 3-sulfate, 24-glucuronide in the serum and urine of children with
severe cholestatic liver disease. J. Lipid Res. 38, 926-934 (1997).
37
Acimovic, J., Lövgren-Sandblom, A., Olin, M., Ali, Z., Heverin, M., Schüle, R., Schöls,
L., Fischler, B., Fickert, P., Trauner, M. & Björkhem, I. Sulphatation does not appear
to be a protective mechanism to prevent oxysterol accumulation in humans and mice.
PLoS One 8, e68031 (2013).
38
Takaki, Y., Mizuochi, T., Takei, H., Eda, K., Konishi, K. I., Ishihara, J., Kinoshita, M.,
Hashizume, N., Yamashita, Y., Nittono, H. & Kimura, A. Urinary and serum
oxysterols in children: developmental pattern and potential biomarker for pediatric
liver disease. Sci. Rep. 10, 6752 (2020).
39
Ikegami, T., Honda, A., Miyazaki, T., Kohjima, M., Nakamuta, M. & Matsuzaki, Y.
Increased serum oxysterol concentrations in patients with chronic hepatitis C virus
infection. Biochem. Biophys. Res. Commun. 446, 736-740 (2014).
40
Kimura, A., Suzuki, M., Murai, T., Kurosawa, T., Tohma, M., Sata, M., Inoue, T.,
Hoshiyama, A., Nakashima, E., Yamashita, Y., Fujisawa, T. & Kato, H. Urinary
7alpha-hydroxy-3-oxochol-4-en-24-oic and 3-oxochola-4,6-dien-24-oic acids in infants
93
with cholestasis. J. Hepatol. 28, 270-279 (1998).
41
Kimura, A., Mahara, R., Inoue, T., Nomura, Y., Murai, T., Kurosawa, T., Tohma, M.,
Noguchi, K., Hoshiyama, A., Fujisawa, T. & Kato, H. Profile of urinary bile acids in
infants and children: developmental pattern of excretion of unsaturated ketonic bile
acids and 7beta-hydroxylated bile acids. Pediatr. Res. 45, 603-609 (1999).
42
Nishiura, H., Kimura, A., Yamato, Y., Aoki, K., Inokuchi, T., Kurosawa, T. &
Matsuishi, T. Developmental pattern of urinary bile acid profile in preterm infants.
Pediatr. Int. 52, 44-50 (2010).
43
Zhou, K., Lin, N., Xiao, Y., Wang, Y., Wen, J., Zou, G. M., Gu, X. & Cai, W. Elevated
bile acids in newborns with Biliary Atresia (BA). PLoS One 7, e49270 (2012).
44
Zhou, K., Wang, J., Xie, G., Zhou, Y., Yan, W., Pan, W., Che, Y., Zhang, T., Wong, L.,
Kwee, S., Xiao, Y., Wen, J., Cai, W. & Jia, W. Distinct Plasma Bile Acid Profiles of
Biliary Atresia and Neonatal Hepatitis Syndrome. J. Proteome Res. 14, 4844-4850
(2015).
45
Helmschrodt, C., Becker, S., Thiery, J. & Ceglarek, U. Preanalytical standardization
for reactive oxygen species derived oxysterol analysis in human plasma by liquid
chromatography-tandem mass spectrometry. Biochem. Biophys. Res. Commun. 446,
726-730 (2014).
94
46
McDonald, J. G., Smith, D. D., Stiles, A. R. & Russell, D. W. A comprehensive method
for extraction and quantitative analysis of sterols and secosteroids from human
plasma. J. Lipid Res. 53, 1399-1409 (2012).
47
Sidhu, R., Jiang, H., Farhat, N. Y., Carrillo-Carrasco, N., Woolery, M., Ottinger, E.,
Porter, F. D., Schaffer, J. E., Ory, D. S. & Jiang, X. A validated LC-MS/MS assay for
quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid. J. Lipid
Res. 56, 1222-1233 (2015).
48
Griffiths, W. J., Crick, P. J., Wang, Y., Ogundare, M., Tuschl, K., Morris, A. A., Bigger,
B. W., Clayton, P. T. & Wang, Y. Analytical strategies for characterization of oxysterol
lipidomes: liver X receptor ligands in plasma. Free Radic. Biol. Med. 59, 69-84 (2013).
49
Tsukada, T., Isoe, M. & Yoshino, M. Hydrolysis of conjugated steroids by betaglucuronidase from Ampullaria and application to the determination of urinary 17hydroxycorticosteroids. Clin. Chim. Acta 160, 245-253 (1986).
50
Muto, A., Takei, H., Unno, A., Murai, T., Kurosawa, T., Ogawa, S., Iida, T., Ikegawa,
S., Mori, J., Ohtake, A., Hoshina, T., Mizuochi, T., Kimura, A., Hofmann, A. F., Hagey,
L. R. & Nittono, H. Detection of Δ4-3-oxo-steroid 5β-reductase deficiency by LC-ESIMS/MS measurement of urinary bile acids. J. Chromatogr. B Analyt. Technol. Biomed.
Life Sci. 900, 24-31 (2012).
95
51
Nittono, H., Takei, H., Unno, A., Kimura, A., Shimizu, T., Kurosawa, T., Tohma, M. &
Une, M. Diagnostic determination system for high-risk screening for inborn errors of
bile acid metabolism based on an analysis of urinary bile acids using gas
chromatography-mass spectrometry: results for 10 years in Japan. Pediatr. Int. 51,
535-543 (2009).
52
Bauman, D. R., Bitmansour, A. D., McDonald, J. G., Thompson, B. M., Liang, G. &
Russell, D. W. 25-Hydroxycholesterol secreted by macrophages in response to Tolllike receptor activation suppresses immunoglobulin A production. Proc. Natl. Acad.
Sci. U. S. A. 106, 16764-16769 (2009).
53
Diczfalusy, U., Olofsson, K. E., Carlsson, A. M., Gong, M., Golenbock, D. T.,
Rooyackers, O., Fläring, U. & Björkbacka, H. Marked upregulation of cholesterol 25hydroxylase expression by lipopolysaccharide. J. Lipid Res. 50, 2258-2264 (2009).
54
Patel, R. P., Diczfalusy, U., Dzeletovic, S., Wilson, M. T. & Darley-Usmar, V. M.
Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite,
myoglobin, and copper. J. Lipid Res. 37, 2361-2371 (1996).
55
Crosignani, A., Del Puppo, M., De Fabiani, E., Caruso, D., Gallisai, D., Mela, M. G.,
Melzi, M. L., Galli Kienle, M. & Colombo, C. Plasma oxysterols in normal and
cholestatic children as indicators of the two pathways of bile acid synthesis. Clin.
96
Chim. Acta 395, 84-88 (2008).
56
Crosignani, A., Zuin, M., Allocca, M. & Del Puppo, M. Oxysterols in bile acid
metabolism. Clin. Chim. Acta 412, 2037-2045 (2011).
57
Reiss, A. B., Martin, K. O., Rojer, D. E., Iyer, S., Grossi, E. A., Galloway, A. C. & Javitt,
N. B. Sterol 27-hydroxylase: expression in human arterial endothelium. J. Lipid Res.
38, 1254-1260 (1997).
58
Bjorkhem, I., Araya, Z., Rudling, M., Angelin, B., Einarsson, C. & Wikvall, K.
Differences in the regulation of the classical and the alternative pathway for bile acid
synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1. J. Biol.
Chem. 277, 26804-26807 (2002).
59
Crosignani, A., Del Puppo, M., Longo, M., De Fabiani, E., Caruso, D., Zuin, M., Podda,
M., Javitt, N. B. & Kienle, M. G. Changes in classic and alternative pathways of bile
acid synthesis in chronic liver disease. Clin. Chim. Acta 382, 82-88 (2007).
60
Del Puppo, M., Kienle, M. G., Petroni, M. L., Crosignani, A. & Podda, M. Serum 27hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of
cholesterol catabolism to bile acids via the acidic pathway. J. Lipid Res. 39, 2477-2482
(1998).
61
Russo, P., Magee, J. C., Anders, R. A., Bove, K. E., Chung, C., Cummings, O. W.,
97
Finegold, M. J., Finn, L. S., Kim, G. E., Lovell, M. A., Magid, M. S., Melin-Aldana, H.,
Ranganathan, S., Shehata, B. M., Wang, L. L., White, F. V., Chen, Z. & Spino, C. Key
Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From
Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A
Multicenter Study. Am. J. Surg. Pathol. 40, 1601-1615 (2016).
62
Gälman, C., Arvidsson, I., Angelin, B. & Rudling, M. Monitoring hepatic cholesterol
7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alphahydroxy-4-cholesten-3-one in peripheral blood. J. Lipid Res. 44, 859-866 (2003).
63
Lee, C. S., Kimura, A., Wu, J. F., Ni, Y. H., Hsu, H. Y., Chang, M. H., Nittono, H. &
Chen, H. L. Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic
cholestasis. J. Lipid Res. 58, 607-614 (2017).
64
Zhao, D., Zhou, K., Chen, Y., Xie, W. & Zhang, Y. Development and validation of bile
acid profile-based scoring system for identification of biliary atresia: a prospective
study. BMC Pediatr. 20, 255 (2020).
65
Konishi, K. I., Yoshida, M., Nakao, A., Tsuchiya, K., Tsurisawa, C., Ichiki, K., Takeda,
T., Hisaeda, Y., Hirota, A., Amagata, S., Odashima, T., Yokomori, K., Ishida, K.,
Matsuura, M., Ito, S., Fujiwara, M. & Nakahara, S. Prostaglandin E-major urinary
metabolite as a noninvasive surrogate marker for infantile necrotizing enterocolitis.
98
J. Pediatr. Surg. 54, 1584-1589 (2019).
66
Idborg, H., Pawelzik, S. C., Perez-Manso, M., Björk, L., Hamrin, J., Herlenius, E. &
Jakobsson, P. J. Evaluation of urinary prostaglandin E2 metabolite as a biomarker
in infants with fever due to viral infection. Prostaglandins Leukot. Essent. Fatty
Acids 91, 269-275 (2014).
99
10. 謝辞
本研究を遂行する機会を与えて下さり、御指導・御鞭撻を賜りました、東京大
学大学院医学系研究科 生殖・発達・加齢医学専攻 小児医学講座 小児外科学分
野 藤代 準 教授に厚く御礼申し上げます。同じく、本研究を遂行するにあたり、
御指導・御鞭撻を賜りました、久留米大学医学部小児科 水落 建輝 先生、木村
昭彦 先生、順伸クリニック胆汁酸研究所 入戸野 博 先生、武井 一 先生に深謝
致します。また、本研究に御協力下さいました、久留米大学医学部小児科 安田
亮輔 先生、坂口 廣高 先生、石原 潤 先生、高木 祐吾 先生、木下 正啓 先生、
山下 裕史朗 先生、久留米大学医学部外科学講座小児外科部門 橋詰 直樹 先生、
深堀 優 先生、順天堂大学医学部附属順天堂医院小児科・思春期科 東海林 宏道
先生、順天堂大学医学部附属順天堂医院小児外科・小児泌尿生殖器外科 宮野 剛
先生、九州大学大学院医学研究院小児外科学分野 吉丸 耕一朗 先生、松浦 俊治
先生、自治医科大学消化器一般移植外科 眞田 幸弘 先生、名古屋大学大学院医
学系研究科小児外科 田井中 貴久 先生、内田 広夫 先生、北海道医療大学大学
院薬学研究科生命物理科学講座薬品分析化学 村井 毅 先生、東北大学病院小児
外科 久保 有美子 先生、田中 拡 先生、佐々木 英之 先生、仁尾 正記 先生に
深謝致します。
100
...
論文の公開元へ
